drugset / Trial / NCT00984386

Investigation of the Efficacy of Zesteem in Accelerating Early Wound Healing

NCT00984386

Phase 2 Completed 44 enrolled Renovo
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate early wound healing of one application of four different doses of intradermal Zesteem (17β-Estradiol) in male subjects and female subjects two years post-menopausal.

Timeline

Start
2005-03
Primary completion
2005-04
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 0.02 ug Other
Subject Estradiol Other / unclassified 0.1 ug Other
Subject Estradiol Other / unclassified 0.2 ug Other
Subject Estradiol Other / unclassified 0.4 ug Other

Indications

No indication recorded.